Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79917.730.0966%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Kala Bio Inc

KALANASDAQ
Trade with Public
Trade with Public
$0.5073
-0.0537-9.57%
At close: Sep 4, 5:00 PM EST
$0.5098
0.00250.49%
After Hours: Sep 4, 7:31 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Kala Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kala Bio (KALA).

Price Target Range — 7 Quarters

Analyst Consensus — 3 Analysts

2Buy
1Hold
Consensus RatingOutperform# Analysts3Avg. Consensus PT$26Upside to Avg. PT+5000.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 29, 2025HC Wainwright & Co.Yi ChenDowngradeBuy→Neutral—
Sep 17, 2025HC Wainwright & Co.Yi ChenPT RaiseBuy$12→$35
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and raises the price target from $12 to $35.
Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio (NASDAQ:KALA) with a Outperform and raises the price target from $15 to $33.
Benzinga Newsdesk

PRO
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio (NASDAQ:KALA) with a Outperform rating and announces Price Target of $30.
Benzinga Newsdesk

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Ladenburg Thalmann Initiates Coverage On Kala Bio with Buy Rating, Announces Price Target of $12

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Kala Bio (NASDAQ:KALA) with a Buy rating and announces Price Target of $12.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $12

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $15 to $12.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved